Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Coughing Causes
 Allergy Medicine & Treatment
 Chronic Obstructive Pulmonary Disease
 Living With Asthma
 Respiratory Illnesses
Featured Conditions
 Allergy
 Asthma
 Cold & Flu
 Stop Smoking
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Researchers Find Gene Mutation That Increases Asthma Risk

Study finds variant and protein it expresses may cause some cases of the disease

By Serena Gordon
HealthDay Reporter


Related Encyclopedia
 border=
Asthma
Asthma in Children
Asthma Treatment
Atelectasis
More...

Related Healthscout Videos
 border=
Detecting Lung Disease
Stents for Emphysema
Stents for Emphysema
Early Asthma Detection
More...

Related Animations
 border=
Asthma
More...

Related Drug Information
 border=
Advair Diskus
Combivent
Flovent
Flovent Diskus
More...

Related News Articles
 border=
Old, Fat Mice Blamed for Virus Transmission
Kick the Habit
Gene Mutation Tied to Inherited Fatal Lung Disease
Antifungal Drug May Help Ease Asthma
More...

WEDNESDAY, April 9 (HealthDay News) -- Just a small change in one gene, called CHI3L1, can increase a person's risk of developing asthma.

The genetic variation in CHI3L1 causes the gene to release high levels of a protein known as YKL-40, and high levels of this protein have been associated with an increased risk of asthma in past research. The current study found that high levels of YKL-40 in four different population groups were linked to the development of asthma in all four groups, suggesting that YKL-40 and CHI3L1 are likely at the root of some cases of asthma.

Text Continues Below



That means if scientists can block YKL-40, they could create a novel, potentially more effective treatment for people with asthma.

"While there won't be one silver bullet for all asthma, we can start to think about tailoring medications to get at the cause, rather than just alleviating asthma symptoms," said study author Carole Ober, a professor of human genetics at the University of Chicago. "These findings give us optimism that one day there will be better treatments, more targeted to the specific cause of asthma."

The findings were published online April 9 by the New England Journal of Medicine and were expected to be in the journal's April 17 print issue.

It's believed that YKL-40 was originally produced by the body as a defensive mechanism against harmful parasitic worms, called helminths, according to Dr. Burton Dickey, chairman of pulmonary medicine at M.D. Anderson Cancer Center in Houston. Dickey said that helminths contained a substance called chitin that is also found in fungi, crustaceans and in insects such as dust mites and cockroaches. YKL-40 is what's known as a chitinase-like protein, because it attaches itself to chitin, possibly alerting the body that chitins are present.

But, Dickey pointed out that in the developed world, chitin infections simply aren't an issue any longer, so now this defense mechanism may be reacting to chitin in harmless settings.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 4/9/2008

Related Links
 border=
From Healthscout's partner site on asthma, MyAsthmaCentral.com
VIDEO: Lung stents help asthmatics to breathe easier
TREATMENT: Medication and lifestyle changes provide asthma relief
DRUGS: Common drugs used to treat asthma





SOURCES: Carole Ober, Ph.D., professor, human genetics, University of Chicago; William Cookson, M.D., professor, respiratory genetics, National Heart and Lung Institute, Imperial College, London, U.K.; Burton F. Dickey, M.D., Clifton D. Howe Distinguished Professor, and chairman, pulmonary medicine, M.D. Anderson Cancer Center, Houston; April 17, 2008, New England Journal of Medicine


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.